Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIg in Optic Neuritis
NCT00000117Phase 3Completed
- Sponsor
- National Eye Institute
- Start
- Aug 1995
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in optic neuritis (ON) comparing IVIg with Placebo (2 arms). Primary endpoint: Improvement in LogMAR Visual Acuity at 6 months. Started Aug 1995; status: completed.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on NCT00000117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000117.